Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Great Debates in Medical Dermatology: Cost vs Efficacy in Psoriasis Treatment
Description
The debate centers on the cost versus efficacy of psoriasis treatments, emphasizing the importance of the patient-provider relationship in determining the best approach to care. The speaker argues for a focus on mutual trust and understanding when making treatment decisions, factoring in patient needs, therapy efficacy, safety, and cost. Modern therapies, particularly interleukin inhibitors, show better long-term efficacy compared to traditional treatments, yet there is concern over the justification of high costs for marginal improvements in efficacy. Generics can significantly reduce drug costs; however, challenges exist with low adoption rates and difficulties in access for patients, especially with rare diseases where generic options may not be viable. The discussion also touches upon the limitations of step therapy in personalized medicine, advocating for a more individualized approach based on comprehensive patient data rather than blanket policies. Overall, the complexities of balancing cost, access to quality care, and personalized treatment in dermatology highlight the ongoing debate in the medical community regarding the best way to address patient needs in light of economic constraints.
View moreConclusions
- The provider-patient relationship is essential for optimal healthcare outcomes.
- Effective decision-making in therapy requires understanding patient needs, drug efficacy, safety, and cost.
- In cases of rare diseases, available treatment options are often limited, complicating the balance between cost and efficacy.
- Biologic therapies may offer superior efficacy, but their high costs raise questions about their overall value to patients.
- Price reductions through generics can significantly lower drug costs, but such reductions require sufficient competition in the market.
- Generics may fail when there is a lack of competitors and affordability remains an issue for patients.
- Legislation and policies surrounding drug pricing can impact patient access to necessary medications.
- Personalized medicine, which considers patient genetics and lifestyle, can lead to better therapy decisions over conventional approaches like step therapy.
- Armstrong, A. W., Puig, L., Joshi, A., Skup, M., Williams, D., Li, J., Betts, K. A., & Augustin, M. (Year). Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis. JAMA Dermatology, Original Investigation.
- Egilman, A. C., Kesselheim, A. S., Avorn, J., Raymakers, A. J. N., & Rome, B. N. (Year). Use of Efficiency Frontiers to Align Prices and Clinical Benefits of Biologic Therapies for Plaque Psoriasis. JAMA Dermatology, Original Investigation.